STAAR Surgical Company

342 articles about STAAR Surgical Company

• Ophthalmologists Implant First Visian Toric ICLs in the US

  11/1/2018

  Toric Implantable Collamer Lens Provides Vision Correction for Patients with Myopia and Astigmatism

• STAAR Surgical ICL Sales Up 46%; Company Raises Outlook for Full Year 2018

  10/31/2018

  STAAR Surgical Company today reported financial results for the third quarter ended September 28, 2018.

• STAAR Surgical to Report Third Quarter Results on October 31, 2018

  10/17/2018

  STAAR Surgical Company today announced that it will release financial results for the third quarter ended September 28, 2018 on Wednesday, October 31, 2018 after the market close.

• STAAR Surgical Announces Approval by the FDA of the Visian Toric ICL for the Correction of Myopia with Astigmatism

  9/13/2018

  STAAR Surgical Company is today announcing that the FDA has granted approval of the PMA Supplement for the Visian Toric ICL for the correction of myopia with astigmatism.

• STAAR Surgical Announces EVO ICL Clinical Program for its 15th Annual Surgical Experts Summit in Vienna, Austria, from September 19 – 21, 2018

  9/12/2018

  STAAR Surgical Company is today announcing the EVO ICL Clinical Program which will be presented by Ophthalmic Surgeons to Ophthalmic Surgeons at its invitation only Surgical Experts Summit expected to be attended by over 250 surgeons and invited clinician guests from forty-three countries.

• STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic Cooperation Agreement

  8/14/2018

  STAAR Surgical Company announced they have entered into a multi-year Strategic Cooperation Agreement to provide STAAR's EVO Visian ICL™ intraocular lenses as a primary and premium option for patients seeking visual freedom from spectacles and contact lenses through refractive eye treatment.

• STAAR Surgical Announces Closing of 1,999,850 Shares of Its Common Stock Offering

  8/10/2018

  STAAR Surgical Company announced today the closing of the previously announced underwritten public offering of 1,999,850 shares of its common stock

• STAAR Surgical Announces Pricing of Public Offering of 1,739,000 shares Of Its Common Stock

  8/8/2018

  STAAR Surgical Company announced the pricing of the previously announced underwritten public offering of 1,739,000 shares of its common stock

• STAAR Surgical Announces Public Offering of Common Stock

  8/7/2018

  STAAR Surgical Company (NASDAQ: STAA), a developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced today the underwritten public offering of 1,739,000 shares of its common stock.

• STAAR Surgical ICL Sales Up 67%; Company Raises Outlook for 2018

  8/1/2018

  STAAR Surgical Company reported financial results for the second quarter ended June 29, 2018.

• STAAR Surgical to Report Second Quarter Results on August 1, 2018

  7/18/2018

  STAAR Surgical Company today announced that it will release financial results for the second quarter ended June 29, 2018 on Wednesday, August 1, 2018 after the market close.

• STAAR Surgical and Kobe Kanagawa Eye Clinic in Japan Announce Strategic Cooperation Agreement

  6/26/2018

  Agreement to provide STAAR's EVO Visian ICL™ lenses as a primary and premium option for patients seeking visual freedom from spectacles and contact lenses through refractive eye treatment.

• STAAR Surgical Announces Resolution of FDA Warning Letter

  6/20/2018

  The lifting of the Warning Letter is the result of a comprehensive remediation program that not only addressed the issues raised by the FDA in the 2014 Warning Letter

• STAAR Surgical Reports First Quarter 2018 Results; Revenue Increases 33 Percent on Accelerating EVO Visian ™ ICL Momentum

  5/2/2018

  STAAR Surgical Company reported financial results for the first quarter ended March 30, 2018.

• STAAR Surgical to Report Fourth Quarter Results on February 28, 2018

  2/14/2018

  STAAR will host a conference call and webcast on Wednesday, February 28 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress.

• STAAR Surgical Reports Third Quarter 2017 Results

  11/8/2017

  Quarterly net sales of $23.5 million up 17% from the prior year quarter.

• STAAR Surgical to Report Third Quarter Results on November 8, 2017

  10/25/2017

  STAAR today announced that it will release financial results for the third quarter ended September 30, 2017 on Wednesday, November 8, 2017 after the market close.

• STAAR Surgical Appoints Scott D. Barnes, M.D. As Chief Medical Officer

  10/2/2017

• STAAR Surgical Names Deborah Andrews As CFO

  9/28/2017

• STAAR Surgical And Seoul/Busan BalGeunSeSang Eye Clinic Announce Strategic Cooperation Agreement

  8/15/2017